Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2019 1
2020 1
2021 3
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of fibronectin accumulation suppresses tumor growth.
Ghura H, Keimer M, von Au A, Hackl N, Klemis V, Nakchbandi IA. Ghura H, et al. Among authors: klemis v. Neoplasia. 2021 Sep;23(9):837-850. doi: 10.1016/j.neo.2021.06.012. Epub 2021 Jul 20. Neoplasia. 2021. PMID: 34298233 Free PMC article.
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.
Schmidt T, Klemis V, Schub D, Mihm J, Hielscher F, Marx S, Abu-Omar A, Ziegler L, Guckelmus C, Urschel R, Schneitler S, Becker SL, Gärtner BC, Sester U, Sester M. Schmidt T, et al. Among authors: klemis v. Nat Med. 2021 Sep;27(9):1530-1535. doi: 10.1038/s41591-021-01464-w. Epub 2021 Jul 26. Nat Med. 2021. PMID: 34312554 Free PMC article.
Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
Ziegler L, Klemis V, Schmidt T, Schneitler S, Baum C, Neumann J, Becker SL, Gärtner BC, Sester U, Sester M. Ziegler L, et al. Among authors: klemis v. EBioMedicine. 2023 Dec;98:104853. doi: 10.1016/j.ebiom.2023.104853. Epub 2023 Oct 28. EBioMedicine. 2023. PMID: 38251468 Free PMC article. No abstract available.
Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens.
Klemis V, Schmidt T, Schub D, Mihm J, Marx S, Abu-Omar A, Ziegler L, Hielscher F, Guckelmus C, Urschel R, Wagenpfeil S, Schneitler S, Becker SL, Gärtner BC, Sester U, Sester M. Klemis V, et al. Nat Commun. 2022 Aug 11;13(1):4710. doi: 10.1038/s41467-022-32321-0. Nat Commun. 2022. PMID: 35953492 Free PMC article.
15 results